MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.transproceed.2008.02.087

Медицинская библиотека · Transplantation proceedings · 2008

University of California at San Francisco criteria can be applied to living donor liver transplantation for hepatocellular carcinoma: single-center preliminary results in 27 patients.

Jiang X-Z, Yan L-N, Wen T-F, Li B, Zeng Y, Zhao J-C, Wang W-T, Yang J-Y, Xu M-Q, Chen Z-Y, Ma Y-K, Li F-G, Gong G

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Living donor liver transplantation (LDLT) can provide life-saving therapy for many patients with hepatocellular carcinoma (HCC), who otherwise would succumb due to tumor progression. However, donor risk must be balanced against potential recipient benefit.

METHODS

From January 2002 to December 2006, a total of 27 LDLT were performed for HCC patients in our center, including 25 right lobe grafts, and 2 dual grafts. Twenty-four (88.89%) met the University of California at San Francisco (UCSF) criteria, whereas 3 (11.11%) did not.

RESULTS

Of our 29 donors, the overall complication rate was 17.24%. Two (6.90%) experienced major complications including intra-abdominal bleeding and portal vein thrombosis in 1, respectively; 3 (10.34%) experienced minor complications: wound steatosis, pleural effusion, and transient chyle leakage in 1, respectively. We did not observe any donor mortality; all donors fully recovered and returned to their previous occupations. No recipient developed small-for-size syndrome. The overall HCC patient survival rates at 1- and 3-years were 84.01% and 71.40%, respectively, similar to those of patients undergoing LDLT for various nonmalignant diseases during the same period (P > .05).

CONCLUSIONS

Although further study is needed to fully assess the risks and benefits of LDLT for both HCC patients and donors, our preliminary results suggested that LDLT offered an acceptable chance and duration of survival for HCC patients. It was not only a relatively safe procedure provided that every effort was taken to minimize donor morbidities, but also beneficial for HCC recipients.

Для цитирования: Jiang X-Z, Yan L-N, Wen T-F, Li B, Zeng Y, Zhao J-C, Wang W-T, Yang J-Y, Xu M-Q, Chen Z-Y, Ma Y-K, Li F-G, Gong G. University of California at San Francisco criteria can be applied to living donor liver transplantation for hepatocellular carcinoma: single-center preliminary results in 27 patients.. Transplantation proceedings. 2008. DOI: 10.1016/j.transproceed.2008.02.087.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.